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Virulence-related type III secretion systems are present in many Gram-negative bacterial pathogens. These complex devices
translocate proteins, called effectors, from the bacterium into the eukaryotic host cell. Here, we identify the product of srfJ, a
Salmonella enterica serovar Typhimurium gene regulated by SsrB, as a new substrate of the type III secretion system encoded by
Salmonella pathogenicity island 2. The N-terminal 20-amino-acid segment of SrfJ was recognized as a functional secretion and
translocation signal specific for this system. Transcription of srfJwas positively regulated by the PhoP/PhoQ system in an SsrB-
dependent manner and was negatively regulated by the Rcs system in an SsrB-independent manner. A screen for regulators of an
srfJ-lacZ transcriptional fusion using the T-POP transposon identified IolR, the regulator of genes involved inmyo-inositol utili-
zation, as an srfJ repressor. Our results suggest that SrfJ is synthesized both inside the host, in response to intracellular condi-
tions, and outside the host, inmyo-inositol-rich environments.
Type III secretion systems (T3SS) are complex devices that arepresent inmanyGram-negative bacteria, including the animal
pathogens Yersinia spp., enteropathogenic Escherichia coli, Pseu-
domonas aeruginosa, Shigella flexneri,Chlamydia spp., and Salmo-
nella enterica, and the plant pathogens or symbionts Pseudomonas
syringae, Ralstonia solanacearum, Erwinia spp., Rhizobium spp.,
and Xanthomonas campestris (29). T3SS allows secretion and
translocation of effector proteins frombacteria to eukaryotic cells.
The injected proteins are often able to interfere with host signal
transduction pathways to enable bacterial invasion and survival in
subcellular niches.
Salmonella enterica is a facultative intracellular bacterium re-
sponsible for gastroenteritis and systemic infections in many ani-
mals, including humans (45). S. enterica virulence depends on two
distinct T3SS, T3SS1 and T3SS2. T3SS1 translocates proteins
through the plasmamembrane of the host cell and is necessary for
invasion, whereas T3SS2 is induced intracellularly, injects effector
through the membrane of the Salmonella-containing vacuole
(SCV), and is essential for survival and proliferation inside host
cells. Both systems, however, depend on each other for efficient
functioning (1). The genes encoding the structural components,
many effectors, and some regulators of T3SS1 and T3SS2 are lo-
cated in two Salmonella pathogenicity islands, SPI1 and SPI2, re-
spectively (16, 17, 21, 41, 44, 54). Some effector proteins are en-
coded by genes outside SPI1 and SPI2.
SsrA (also named SpiR) and SsrB are the sensor and the re-
sponse regulator, respectively, of a two-component regulatory
system encoded by SPI2 that is necessary for the expression of
T3SS2 (9, 28, 44). A genetic screen identified 12 genes (named srfA
to srfM, for SsrB-regulated factors) outside SPI2 that were regu-
lated by SsrB (62). These genes were located in horizontally ac-
quired regions and, because of their pattern of expression, were
suggested as candidates to encode T3SS2 effectors (61, 62). How-
ever, to date, the product of only one of these genes, srfH (also
named sseI), has been demonstrated to be translocated into host
cells through T3SS2 (39). One of the most interesting genes iden-
tified in this screen was srfJ. An srfJ null mutant has a slight viru-
lence defect (49).More interestingly, the product of this gene, SrfJ,
is similar to human lysosomal glucosylceramidase, an enzyme in-
volved in regulating metabolism of ceramide, one of the most
intensely studied classes of sphingolipids (4, 30).
The potential of srfJ prompted us to investigate in detail its
pattern of expression and the possibility of secretion of its prod-
uct, SrfJ, through a T3SS. Here, we show that SrfJ can be secreted
in vitro and that the amino-terminal region of this protein directs
translocation into macrophages specifically through T3SS2. srfJ is
regulated not only by SsrB but also by PhoP, RcsB, and, surpris-
ingly, by IolR, the main regulator of genes involved inmyo-inosi-
tol utilization (33).
MATERIALS AND METHODS
Bacterial strains, bacteriophages, and strain construction. E. coli and S.
enterica serovar Typhimurium strains used in this study are described in
Table 1. Salmonella strains derive from the mouse-virulent strain ATCC
14028. Transductional crosses using phage P22HT 105/1 int201 (53) were
used for strain construction (37). To obtain phage-free isolates, transduc-
tants were purified by streaking on green plates (6). Phage sensitivity was
tested by cross-streaking with the clear-plaque mutant P22 H5.
Bacterial culture. The standard culture medium for S. enterica and E.
coli was Luria-Bertani broth (LB). Solid LB contained 1.5% agar (final
concentration). Antibiotics were used at the following concentrations:
kanamycin (Km), 50 g ml1; chloramphenicol (Cm), 20 g ml1;
ampicillin (Ap), 100 g ml1; and tetracycline (Tc), 20 g ml1. Subin-
hibitory concentrations of polymyxin B sulfate (Sigma) used in some
experiments were 1 g ml1 in LB and 5 g ml1 in LPM. For some
experiments, 40g ml1 5-bromo-4-chloro-indolyl--D-galactopyrano-
side (X-Gal) or 55.5mMmyo-inositol was added. For SPI1-inducing con-
ditions, Salmonella strains were grown overnight at 37°C in LB–0.3 M
NaCl medium in static conditions. For SPI2-inducing conditions, cells
from cultures in LBwere washed and diluted 1:125withminimalmedium
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at pH 5.8 (LPM) containing 80 mM 2-(N-morpholino)ethanesulfonic
acid (pH 5.8), 5 mM KCl, 7.5 mM (NH4)2SO4, 0.5 mM K2SO4, 0.1%
Casamino Acids, 38 mM glycerol, 337.5 MK2HPO4-KH2PO4 (pH 7.4),
and 8MMgCl2, and then incubated overnight at 37°Cwith shaking. For
some experiments, the concentration of MgCl2 or the pH of the medium
was modified as indicated. Arabinose was used at a final concentration of
0.2%.
DNA amplification with PCR. Amplification reactions were carried
out in a Perkin Elmer Gene-Amp PCR system 2400 (Perkin Elmer Cetus).
The final volume of reactions was 50 l, and the final concentration of
MgCl2 was 1.5 mM. Reagents were used at the following concentrations:
deoxynucleoside triphosphates (dNTPs), 300 M; primers, 0.3 M; and
Taqpolymerase (KAPAHiFiDNAPolymerase; KapaBiosystems), 1Uper
reaction. The thermal program included the following steps: (i) initial
denaturation for 5min at 95°C; (ii) 25 cycles of denaturation (98°C, 20 s),
annealing (57°C, 15 s), and extension (72°C, 30 s); and (iii) final incuba-
tion at 72°C for 5 min to complete the extension. Primers are listed in
Table 2. PCR constructs were sequenced with an automated DNA se-
quencer (Stab Vida, Oeiras, Portugal) to confirm that the sequence was
correct.
Plasmids. Plasmids used in this study are listed in Table 1. Plasmids
expressing CyaA= fusions were derivatives of pIZ1673, a modification of
pSIF003-R1 (58) (a gift from I. Rosenshine, The Hebrew University of
Jerusalem) thatwas constructed by deletion of the lacI gene using enzymes
HpaI and SphI. Therefore, expression of CyaA fusions from derivatives of
pIZ1673 is no longer dependent on isopropyl--D-thiogalactopyranoside
(IPTG). To construct these plasmids, DNA from strain 14028 was used as
a template for PCR amplification with the primers listed in Table 2. The
amplified fragments were digested with BamHI and ligated with BamHI-
digested and dephosphorylated pIZ1673. To detect successful constructs
(plasmid with insert in the correct orientation), the ligation mixture was
transformed into E. coli TP610 and transformants were selected in Mac-
Conkey agar supplemented with Ap and 1% maltose. TP610 is a cyamu-
tant strain (22) that can be complementedwith the basal adenylate cyclase
activity that possesses CyaA from Bordetella pertussis in the absence of
calmodulin. Transformants with empty plasmids or with inserts in the
wrong orientation give white colonies in MacConkey-maltose, whereas
plasmids with inserts in the correct orientation give red colonies in the
same medium. Derivatives of plasmid pBAD18 were used for comple-
mentation studies. To construct pIZ1973 and pIZ1974, iolR and phoP,
TABLE 1 Bacterial strains and plasmids used in this study
Strain or plasmid Relevant characteristic(s) Source or reference
E. coli strains
DH5 supE44 lacU169 (80 lacZM15) hsdR17 recA1 endA1 gyrA96 thi-1 relA1 26
TP610 F thi-1 thr-1 leuB6 lacY1 tonA21 supE44 hsdR hsdM recBC lop-11 ligcya-610 27
S. enterica serovar Typhimurium strains
14028 Wild type ATCC
55130 14028 pho-24 (PhoP constitutive) E. A. Groisman
SV4699 14028 phoP7953::Tn10 Laboratory stock
SV4758 14028 rcsC55 19
SV5049 14028 rcsB::Cmr Laboratory stock
SV5093 14028 rcsA::Cmr 18
SV5136 14028 ssaV::Cmr Laboratory stock
SV5373 14028 hilA Laboratory stock
SV5379 14028 prgH Laboratory stock
SV5452 14028 ssrB::Cmr 18
SV5470 14028 ssaV::lacZ 18
SV5599a 14028 srfJ::3FLAG Kmr This study
SV5600a 14028 srfJ::lacZ This study
SV5604 14028 prgH ssaV::Cmr Laboratory stock
SV6017 14028 SPI2::Cmr Laboratory stock
SV6055 14028 SPI1::Kmr Laboratory stock
SV6891 14028 iolR::Cmr This study
Plasmids
pBAD18 bla PBAD promoter 25
pCE36 aph FRT lacZY this oriR6K 15
pCP20 bla cat cI857 	PR flp pSC101 oriTS 7
pKD3 bla FRT cat FRT PS1 PS2 oriR6K 11
pKD4 bla FRT aph FRT PS1 PS2 oriR6K 11
pKD46 bla PBAD gam bet exo pSC101 oriTS 11
pIZ1673 pSIF003-R1 lacI 5
pIZ1843 pIZ1673-SrfJ This study
pIZ1844 pIZ1673-SrfJ(1-42) This study
pIZ1856 pIZ1673-SrfJ(1-20) This study
pIZ1897 pIZ1673-SrfJ(1-10) This study
pIZ1898 pIZ1673-SrfJ(10-42) This study
pIZ1899 pIZ1673-SrfJ(20-42) This study
pIZ1973 pBAD18-iolR This study
pIZ1974 pBAD18-phoP This study
a Derivatives of these strains were used as indicated in the text.
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respectively, were PCR amplified with the primers indicated in Table 2,
which introduce EcoRI and HindIII sites. Digestions with these enzymes
were used for oriented cloning in pBAD18.
Mammalian cell culture. RAW264.7 cells (murine macrophages;
ECACC no. 91062702) were cultured in Dulbecco’s modified Eagle me-
dium (DMEM) supplemented with 10% fetal calf serum; 2 mM L-glu-
tamine, 100 U/ml penicillin, and 100 g/ml streptomycin were included
in the culture media. Cells were maintained in a 5% CO2 humidified
atmosphere at 37°C.
Constructionofmutants andof a chromosomal lacZ fusion.Disrup-
tion and replacement of srfJ with a Km resistance gene and of iolR with a
Cm resistance gene were performed as described previously (11). Briefly,
the Km resistance gene from plasmid pKD4 or the Cm resistance gene
from plasmid pKD3 was PCR amplified with primers srfJP1 and srfJP2 or
with primers iolRP1 and iolRP2, respectively. The sequences of the prim-
ers used are shown in Table 2. The PCR products were used to transform
the wild-type strain carrying the Red recombinase expression plasmid
pKD46. The antibiotic resistance cassette introduced by the gene-target-
ing procedure was eliminated by recombination using the FLP helper
plasmid pCP20 (11). The FRT site (FLP recombinase recognition target)
generated by excision of the antibiotic resistance cassette in srfJ was used
to integrate plasmid pCE36 to generate a transcriptional lacZ fusion (15).
TABLE 2 Oligonucleotides used in this study
Oligonucleotide and use Sequence (5=–3=)
Insertion in srfJ
srfJP1 CAGATCGACTCCTGCCGCCATAGCAACGTACTGGCGCCTGGTGTAGGCTGGAGCTGCTTC
srfJP2 ATGAAAGGCAGACTCATCTCTTCCGATCCGTATCGTCAGCCATATGAATATCCTCCTTAG
Insertion in iolR
iolRP1 TGGTTATTTACGAAATTTTCGTTCTATTAGAGTATCATGCGTGTAGGCTGGAGCTGCTTC
iolRP2 AATGCCGATGATCGCTAAATACGATCATCGGCTTGTTTTTCATATGAATATCCTCCTTAG
Epitope tagging of srfJ
srfJP1flag GTCAGGCGCCAGTACGTTGCTATGGCGGCAGGAGTCGATCGACTACAAAGACCATGACGG
srfJP2flag TTCGCATACAGGTCGCTTCATTAAATCCCAGCTTCATCATCATATGAATATCCTCCTTAG
Construction of pIZ1843
srfJbampsif5= GAATGGATCCAGGAGGTTCCCTATGAAAGGCAGACTCATCTC
srfJbampsif3= CAAGGGATCCAGATCGACTCCTGCCGCCATAG
Construction of pIZ1844
srfJbampsif5=
srfJ42bampsif3= CAAGGGATCCGTAACGCGTGGCGCGGTAAGAC
Construction of pIZ1856
srfJbampsif5=
srfJ20bampsif3= CAAGGGATCCCCGCACGCTCAACAAGGAATTG
Construction of pIZ1897
srfJbampsif5=
srfJ10bampsif3= CAAGGGATCCACGGATCGGAAGAGATGAGTC
Construction of pIZ1898
srfJ10bampsif5= GAATGGATCCAGGAGGTTCCCTATGCCGTATCGTCAGCAATTCCTTG
srfJ42bampsif3=
Construction of pIZ1899
srfJ20bampsif5= GAATGGATCCAGGAGGTTCCCTATGGCGGTCTCTTTTTCGCATCG
srfJ42bampsif3=
Construction of pIZ1973
iolReco5= CTAGGAATTCAGGAGGTCATGCATGTCTAAACATCAAAC
iolRhind3= CATGAAGCTTTTACTCCGTCGCCAGCGCCAG
Construction of pIZ1974
phoPeco5= CTAGGAATTCAGGAGGAAGAGATGATGCGCGTACTG
phoPhind3= CATGAAGCTTTTAGCGCAATTCAAAAAGATATC
ST-PCR
tpop1 GCCTTCTTATTCGGCCTTGAATTGATCATATGCGG
tpop2 CTTTTTCCGTGATGGTAACC
st1 GGCCACGCGTCGACTAGTAC
stACGCC GGCCACGCGTCGACTAGTACNNNNNNNNNNACGCC
stGATAT GGCCACGCGTCGACTAGTACNNNNNNNNNNGATAT
Cordero-Alba et al.
4228 jb.asm.org Journal of Bacteriology
Chromosomal gene epitope tagging. Addition of a DNA fragment
encoding the 3 FLAG epitope tag at the 3= end of srfJ (designated SrfJ-
3FLAG) was carried out as described previously (57) using primers
srfJP1flag and srfJP2flag.
-Galactosidase assays. Levels of -galactosidase activity were as-
sayed for stationary-phase cultures in LB or in minimal medium as de-
scribed previously (40) using the CHCl3/SDS permeabilization proce-
dure.
Western blotting and antibodies. Salmonella strains were grown un-
der different conditions. Usually, cultures in LBmediumwere diluted and
grown in different media. The bacteria were then pelleted by centrifuga-
tion and resuspended in SDS-PAGE sample buffer. Proteins from the
same numbers of bacteria were separated by gradient SDS-PAGE (Mini-
Protean TGX precast gels; 4 to 15%; Bio-Rad) and electrophoretically
transferred to nitrocellulose filters for Western blot analysis using anti-
Flag M2 monoclonal antibodies (1:5,000; Sigma), anti-GroEL polyclonal
antibodies (1:20,000; Sigma), or anti-DnaK (8E2/2)monoclonal antibod-
ies (1:5,000; Assay Designs). Goat anti-mouse horseradish peroxidase
(HRP)-conjugated antibodies (1:5,000; Bio-Rad) and goat anti-rabbit
HRP-conjugated antibodies (1:10,000; GE Healthcare) were used as sec-
ondary antibodies.
Protein secretion analysis. Salmonella strain SV5599 (14028 express-
ing SrfJ-3FLAG) and prgH or ssaV derivatives were grown overnight in
LPM at pH 5.8, followed by 1 h of incubation at pH 7.2 or overnight
incubation in LB supplemented with 55.5 mM myo-inositol. Whole cells
and culture supernatants were separated by centrifugation at 13,000 g
for 10 min. The supernatants were filtered (0.22-m pore size) and incu-
bated for 30 min on ice with 0.02% deoxycholate. Proteins were then
precipitated by adding trichloroacetic acid at a final concentration of 10%
(vol/vol), followed by incubation at20°C for 5min, placement on ice for
15 min, and then centrifugation (13,000 g, 4°C, 15 min). The superna-
tant was discarded and the pellet was incubated with 300 l of cold ace-
tone for 15 min on ice. After a new centrifugation step, the pellet and the
whole cells were processed for electrophoresis and Western blotting.
Bacterial infection of cultured cells. RAW 264.7 cells were plated in
24-well plates at 1.5  105 cells per well and incubated for 24 h at 37°C
with 5% CO2. Bacteria were grown in LB medium for 24 h at 37°C with
shaking and were added at a multiplicity of infection (MOI) of 250. Bac-
teria were centrifuged onto the cell monolayer at 200  g for 5 min and
then incubated at 37°C with 5% CO2. The cell culture was washed twice
with phosphate-buffered saline (PBS) 1 h postinfection, overlaid with
DMEM containing 100 g ml1 gentamicin, and incubated for another
hour. The culture was then washed twice with PBS, covered with DMEM
with gentamicin (16 g ml1), and incubated for 14 h.
Protein translocation assays. Following the infections described
above, the translocation of SrfJ-CyaA fusions into the eukaryotic cells was
monitored by measuring the levels of cyclic AMP (cAMP). The infected
cells were lysed and the levels of cAMP in the lysates were determined
using a colorimetric direct cAMP enzyme immunoassay kit (Arbor As-
says) according to the manufacturer’s instructions.
Mutagenesis with T-POP. Strain 14028 of S. enterica serovar Typhi-
murium was mutagenized with T-POP, a derivative of Tn10dTc (48).
Pools of 5,000 colonies, each carrying an independent T-POP insertion,
were then prepared and lysedwith phage P22HT. The lysates were used to
transduce strain SV5600 (14028 srfJ::lacZ), with selection of Tc-resistant
transductants on LB plates supplemented with X-Gal, Tc, and Km.
Molecular characterization of T-POP insertions. A semirandom,
two-step PCRprotocol, ST-PCR (8), was used to amplify genomic regions
adjacent to the T-POP insertions. The first reaction was carried out on
bacterial colonies with primers tpop1 and stACGCC or stGATAT (Table
2) in a final volume of 25 l using a thermal program with the following
steps: (i) initial denaturation for 2 min at 94°C; (ii) 6 cycles of denatur-
ation (94°C, 30 s), annealing (42°C, 30 s,1°C for each cycle), and exten-
sion (72°C, 3 min); (iii) 25 cycles of denaturation (94°C, 30 s), annealing
(65°C, 30 s), and extension (72°C, 3min); and (iv) final incubation at 72°C
for 7min to complete extension. The second reactionwas carried out with
primers tpop2 and st1 using 1l of a 5-fold dilution of the product of the
first reaction. The thermal program for the second reaction was (i) initial
denaturation for 30 s at 94°C; (ii) 30 cycles of denaturation (94°C, 30 s),
annealing (56°C, 30 s), and extension (72°C, 2 min); and (iii) final incu-
bation at 72°C for 7 min to complete extension. The final product was
sequenced using primers tpop2 and st1. Sequence analysis was performed
with molecular biology algorithms from the National Center for Biotech-
nology Information at www.ncbi.nlm.nih.gov.
RESULTS
srfJ is expressed under SPI2-inducing conditions. In the course
of an infection, S. enterica receives different environmental cues
that lead to expression of T3SS1 or T3SS2 and translocation into
the host cells of their cognate effectors. Different host environ-
ments can be partially mimicked in vitro using different culture
conditions: overnight incubationwith low aeration in LBmedium
supplemented with 0.3 M NaCl favors expression of T3SS1, and
culture in LPM medium at pH 5.8 with good aeration induces
expression of T3SS2. A lacZ transcriptional fusion was used to
study the pattern of expression of srfJ. Data shown in Fig. 1A
indicated that srfJ was transcribed specifically under T3SS2-in-
ducing conditions. Increases in pH or Mg2 concentration dra-
matically reduced transcription of srfJ, indicating that these were
relevant factors in the regulation of the expression of this gene.
The results at the transcriptional level were confirmed at the pro-
tein level using an SrfJ-3FLAG fusion and immunoblotting with
an anti-FLAG antibody (Fig. 1B).
SrfJ is secreted into the culture media under SPI2-inducing
conditions. Although coexpression of srfJ with T3SS2 (shown in
the previous section) and regulation by SsrB (62) are consistent
with a role of SrfJ as a substrate of T3SS2, secretion of this protein
had not been previously shown. A derivative of strain 14028 of S.
enterica serovar Typhimurium expressing a SrfJ-3FLAG fusion
was used to test secretion into the culture medium. Initial at-
tempts to detect the protein in the supernatants of overnight cul-
tures in LPM (pH 5.8) were unsuccessful. Secretion of many
T3SS2 effectors into the culturemedium can be triggered by shift-
ing the pH of the culture medium from 5.8 to 7.2 during the last
hour of incubation (65). Indeed, these conditions allowed detec-
tion of SrfJ in the culture supernatant. DnaK, a cytosolic protein
used as a control, was not detected, as expected (Fig. 2). Interest-
ingly, secretion of SrfJ was significantly reduced in an ssaVmutant
(SsaV is an essential component of T3SS2), suggesting that secre-
tion of SrfJ was, at least partially, dependent on T3SS2 under these
in vitro conditions.
The N-terminal portion of SrfJ directs translocation into
macrophages through T3SS2.We decided to test the transloca-
tion of SrfJ into host cells. To this end, we used a sensitive
method based on the generation of fusions with the catalytic
domain of CyaA from Bordetella pertussis, a calmodulin-de-
pendent adenylate cyclase. Calmodulin is not produced in bac-
teria but is present in eukaryotic host cells. After infection of
eukaryotic cell cultures with bacteria expressing a CyaA= fu-
sion, translocation is detected as an increase in the concentra-
tion of cAMP, whose production is catalyzed by adenylate cy-
clase. Analysis of the sequence of SrfJ, a protein of 447 amino
acids, revealed the presence of a C-terminal domain similar to
glucosylceramidases starting at amino acid 43. Since transloca-
tion signals of T3SS effectors are usually located in the N-ter-
minal portion of the protein, we generated a CyaA fusion with
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amino acids 1 to 42 of SrfJ expressed from a constitutive pro-
moter in a plasmid. A derivative of S. enterica serovar Typhi-
murium 14028 carrying this plasmid was used to infect cultures
of RAW264.7 macrophages. An increase in the level of cAMP in
the culture 16 h postinfection indicated translocation of the
fusion into the cytosol of the host cells (Fig. 3A). Fragment 1-20
of SrfJ, but not fragment 1-10, 10-42, or 20-42, was also able to
direct translocation of CyaA into macrophages. Fusions with
fragments 1-42 and 1-20 were also translocated in a strain lack-
ing T3SS1 (SPI1), but they were no longer translocated in a
strain lacking T3SS2 (SPI2) (Fig. 3B). These results suggest
that the N-terminal 20 amino acids of SrfJ are enough to direct
translocation into macrophages specifically through T3SS2.
Expression of srfJ is regulated positively by SsrB and PhoP
and negatively by RcsB. The srfJ::lacZ transcriptional fusion and
the SrfJ-3FLAG fusion were used to search for regulators of this
gene. The expression of the fusions was analyzed in LPM using
Salmonella strains with mutations in genes encoding known viru-
lence regulators: PhoP, SsrB, HilA, and RcsB. In addition to null
mutations, the activating mutations pho-24 and rcsC55 were also
used. As seen in Fig. 4A and B, PhoP and SsrB were necessary for
expression of srfJ in LPM. Expression of srfJ was increased in a
pho-24 background, confirming that PhoP was a positive regula-
tor of this gene. Additional confirmation was provided by com-
plementation analysis. Plasmid pIZ1974, carrying the phoP gene
under the control of the arabinose-inducible PBAD promoter, was
constructed for this purpose. Arabinose-induced phoP expres-
sion, but not the empty vector (pBAD18), complemented the ef-
fect of phoP disruption and activated srfJ expression (Fig. 4C). The
phoP mutant used in our experiments was the product of a Tn10
insertion that is expected to have a polar effect on phoQ. Partial
complementation due to expression of phoP alone is explained by
overexpression of the transcriptional regulator PhoP, which can
activate its target genes in a PhoQ-independent manner (34). In
addition, overactivation of the Rcs system by the rcsC55mutation
prevented srfJ transcription, suggesting that RcsB is a negative
regulator of srfJ. This conclusion was confirmed using a rcsB::
Cmr mutation: introduction of this null mutation in the rcsC55
mutant restored wild-type levels of srfJ::lacZ transcription (Fig.
4D). In contrast, a rcsA::Cmr mutation was unable to suppress
the effect of the rcsC55 mutation on the expression of srfJ::lacZ,
FIG 1 Expression of srfJ in differentmedia. Bacteria were incubated overnight
at 37°C with shaking in LPM or without shaking in LB with 0.3 M NaCl (LB).
Different pH and Mg2 concentrations were used as indicated. (A) -Galac-
tosidase activities weremeasured from cultures of an S. enterica strain carrying
a chromosomal srfJ::lacZ transcriptional fusion. Means and standard devia-
tions from duplicate experiments are represented. (B) Expression at the pro-
tein level was studied by Western blotting using a strain expressing SrfJ-
3FLAG. Extracts from this strain were resolved by SDS-PAGE (4 to 15%
gradient), and a monoclonal anti-FLAG antibody was used for immunoblot-
ting (upper panel). Polyclonal anti-GroEL antibody was used to get a loading
control (lower panel).
FIG 2 SrfJ is secreted into the culture medium through T3SS2. A derivative of strain 14028 of S. enterica serovar Typhimurium expressing SrfJ-3FLAG either
was grownovernight in LPMat pH5.8 orwas grownovernight in LPMat pH5.8, the pH shifted to 7.2, and the incubation continued for an additional hour. After
centrifugation, the supernatants were filtered and precipitated. The supernatants and aliquots of the pellets (cell lysates) were submitted to SDS-PAGE and
immunoblotting with anti-FLAG antibodies (upper panels) and with anti-GroEL or anti-DnaK antibodies (lower panels). The same experiment was carried out
in an ssaVmutant (lacking T3SS2), as indicated. wt, wild type.
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indicating that the coregulator RcsA does not participate in the
regulation of srfJ transcription. pho-24 ssrB and pho-24 rcsC55
double mutants were constructed to carry out epistasis analysis.
The results shown in Fig. 4 suggested that PhoP activates srfJ
through SsrB, whereas RcsB acts independently. Since both the
Rcs and the PhoP/PhoQ systems are activated by cationic antimi-
crobial peptides, we decided to study the effect of subinhibitory
concentrations of polymyxin B on srfJ expression. No significant
modifications in the expression of srfJ::lacZ were detected after
addition of polymyxin B to LB–0.3 M NaCl or to LPM (data not
shown). This result is consistent with the opposite effects that
these regulatory systems have on srfJ.
AT-POP-based screen identifies IolR as a negative regulator
of srfJ transcription. We took advantage of the srfJ::lacZ fusion
and the T-POP transposon to look for new regulators of srfJ. A
pool of randomT-POP insertions was generated in strain SV5600,
a derivative of strain 14028 of S. enterica serovar Typhimurium
carrying an srfJ::lacZ fusion. Tc-resistant isolates were selected on
LB plates supplemented with Tc and the chromogenic indicator
X-Gal. Most colonies were white, as expected, since srfJ shows a
very low level of expression in this medium. However, 15 colonies
out of 20,000 screened were blue. All were also blue in the absence
of tetracycline, suggesting that their phenotypes were due to dis-
ruption of a regulatory gene by T-POP and not to the Tc-depen-
dent overexpression of an adjacent gene(s) from a T-POP pro-
moter (48). To identify the location of the T-POP insertion, a
semirandom, two-step PCR protocol (described in Materials and
Methods) was used to amplify the DNA adjacent to the trans-
poson for sequencing. All of the isolates carried the T-POP trans-
poson in the same gene: STM14_5307 (STM4417 in strain LT2),
also known as iolR (33). To confirm the results, an iolR null mu-
tant was constructed using 	Red recombineering, and the expres-
sion of srfJ::lacZwasmeasured in wild-type and iolR backgrounds.
The iolRmutation caused a
200-fold increase in-galactosidase
activity of LB–0.3 M NaCl cultures (Fig. 5A). This increase was
confirmed by immunoblotting using the SrfJ-3FLAG fusion
(Fig. 5B). Epistasis analysis showed that this regulation was inde-
pendent of SsrB and PhoP (Fig. 5A and B). Similar experiments
carried out in LPM (pH 5.8) showed that the iolR mutation was
unable to increase expression of srfJ in this medium (Fig. 5C and
D). Interestingly, this mutation increased expression of srfJ in a
phoP or an ssrB background (compare data in Fig. 4 and 5). Ad-
ditional support for the conclusion that IolRwas a repressor of srfJ
transcription was provided by complementation analysis. As seen
in Fig. 5E, derepression of srfJ::lacZ transcription in LB–0.3 M
NaCl caused by disruption of iolRwas abolished by a derivative of
plasmid pBAD18 expressing wild-type iolR from a PBAD promoter
(plasmid pIZ1973) but not by the empty vector. Complementa-
tionwas confirmed at the protein level in the strains expressing the
SrfJ-3FLAG fusion (Fig. 5F).
myo-inositol induces transcription of srfJ but not secretion
into the medium. The iolR gene product was described as a neg-
ative regulator of genes involved in myo-inositol utilization in S.
enterica serovar Typhimurium (33). The presence ofmyo-inositol
is expected to prevent binding of IolR to promoters. Therefore, we
tested the effect of myo-inositol on the expression of srfJ at both
the transcriptional and protein level. As seen in Fig. 6A and B,
addition of 55.5 mM myo-inositol to LB–0.3 M NaCl induced
expression of srfJ to the same level as that obtained for the iolR
mutant in LB–0.3 M NaCl in a PhoP-, SsrB-, and RcsB-indepen-
dent manner. SrfJ-3FLAG was not detected, however, in the
supernatant of cultures in LB–0.3MNaCl withmyo-inositol (Fig.
6B), indicating that myo-inositol induces expression but not se-
cretion under these conditions. The effect of myo-inositol on srfJ
expression seems to be specific, since transcription of ssaV, an-
other SsrB-regulated gene used for comparison, was not affected
bymyo-inositol (Fig. 6A). Finally, we compared the growth of the
wild-type strain to that of a strain lacking srfJ in minimal medium
with myo-inositol as the sole carbon source. No differences were
observed (data not shown), indicating that SrfJ is not involved in
the utilization ofmyo-inositol.
FIG 3 The 20 N-terminal amino acids of SrfJ are able to direct translocation into macrophages through T3SS2. (A) Different fragments of SrfJ were expressed
in the wild-type strain of S. enterica serovar Typhimurium in fusion with the catalytic domain of CyaA from B. pertussis. RAW264.7 cells were infected with
bacteria grown for 24 h in LB at 37°C with shaking, and the concentrations of cAMP were measured 16 h postinfection. Numbers in parentheses indicate the
amino acids of SrfJ included in the fusion. The results are represented as themeans from four independent experiments. Error bars represent standard deviations.
(B) Fragments containing amino acids 1 to 42 and 1 to 20 from SrfJ fused to the catalytic domain of CyaA from B. pertussis were expressed in the wild-type (wt)
strain of S. enterica serovar Typhimurium, in a strain lacking T3SS1 (SPI1), and in a strain lacking T3SS2 (SPI2). Cultures from these bacteria were used to
infect RAW264.7 cells, and the concentrations of cAMP were measured 16 h postinfection. Means and standard deviations from two independent experiments
are represented.
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DISCUSSION
Characterization of the whole catalogue of effector proteins is an
important step in the understanding of the pathogenesis of bacte-
ria that rely on T3SS for their interaction with the host. Although
the components of the secretion apparatus are well conserved be-
tween distantly related bacteria, the secreted proteins are usually
very different. This is a hurdle in the identification of effector
proteins, in spite of the increasing availability of whole-genome
sequences. Proteomic and genetic screens have led to the identifi-
cation of many effectors in different bacteria but the catalogue of
effectors is still growing, indicating that it is not completed yet (12,
20, 43, 46, 51, 52, 55).
In this work, we provide evidence suggesting that SrfJ, the
product of an SsrB-regulated gene, is a new substrate of Salmonella
T3SS2. Regulation by SsrB is a feature shared by most T3SS2 ef-
fectors encoded inside or outside SPI2. Therefore, all srf genes (62)
were, in principle, candidates to encode such an effector. For in-
stance, SrfH, also called SseI, was shown to be translocated
through T3SS2 into the host cytosol (39), where it binds the actin-
cross-linking protein filamin and colocalizes with polymerizing
actin in the cytoskeleton and with TRIP6 (38, 63). There was no
evidence of translocation for the other srf gene products. Previous
work in our laboratory showed that the srfABC operon is not
expressed in coordination with SPI2; therefore, its products, SrfA,
SrfB, and SrfC, are not expected to be secreted through T3SS2
(18). In addition, no translocation was detected for SrfK using the
CyaA fusion system (our unpublished results).
Translocation of SrfJ into macrophages was dependent on
T3SS2 and independent of T3SS1. In addition, secretion of SrfJ
into the culturemediumoccurred only under SPI2-inducing con-
ditions, although a shift from pH 5.8 to 7.2 was essential to detect
the protein in the supernatant of the cell cultures. Experiments by
Yu et al. (65) suggest that the SPI2-encoded proteins SsaL, SsaM,
and SpiC form a complex that is required for secretion of translo-
con proteins and suppress secretion of effectors at pH 5.0. Expo-
sure to pH 7.2 after growth at pH 5.0 causes dissociation and
FIG 4 srfJ is regulated by PhoP, SsrB, and RcsB. (A)-Galactosidase activities weremeasured from cultures in LPMof several S. enterica strains: 14028 (wild type
[wt]), null mutants (phoP, ssrB, hilA, and rcsB), mutants with constitutive activation of the PhoP/PhoQ or the Rcs system (pho-24 and rcsC55, respectively), and
double mutants (pho-24 ssrB and pho-24 rcsC55), all of them carrying a chromosomal srfJ::lacZ transcriptional fusion. Means and standard deviations from
duplicate experiments are represented. (B) Expression at the protein level was studied byWestern blotting using strains expressing SrfJ-3FLAG. Extracts from
these strains were resolved by SDS-PAGE (4 to 15% gradient), and amonoclonal anti-FLAG antibody was used for immunoblotting (upper panel). A polyclonal
anti-GroEL antibody was used to get a loading control (lower panel). (C) A plasmid expressing wild-type phoP (phoP) under a PBAD promoter was used to
complement the effect of a null phoP mutation on srfJ transcription. The empty vector (pBAD18) was used as a control. Means and standard deviations of
-galactosidase activities obtained from strains carrying a chromosomal srfJ::lacZ transcriptional fusion grown in LPM supplemented with 0.2% arabinose are
represented. (D) To study the role of RcsB and RcsA in the regulation of srfJ, -galactosidase activities were measured from cultures in LPM of wild-type (wt) S.
enterica ormutants, as indicated, all of them carrying a chromosomal srfJ::lacZ transcriptional fusion.Means and standard deviations fromduplicate experiments
are represented.
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degradation of the complex and allows effector secretion. The
same requirement was previously observed for other T3SS2, like
SseF and SseJ (65), but not for other effectors, like SteA, that can
also be secreted through T3SS1 (5).
In most T3SS effectors studied, a small N-terminal domain is
enough to direct translocation, although a conserved sequence has
been identified in only a few cases (39). As a consequence, com-
putational methods used to detect secretion signals are only par-
tially accurate (2, 36, 50, 60, 64). Our experiments with SrfJ frag-
ments fused to CyaA showed that the minimal signal sequence
necessary for translocation is contained in the N-terminal 20
amino acids of this protein. This short sequence was enough to
direct translocation of CyaA specifically through T3SS2, suggest-
ing that in this case interaction with a chaperone, as has been
described for other effectors, was dispensable.
As expected for a T3SS2 effector, expression of srfJ is coordi-
FIG 5 IolR represses srfJ. Expression of srfJ at the transcriptional level was monitored using a chromosomal srfJ::lacZ fusion. -Galactosidase activities were
measured in LB–0.3MNaCl (A) or LPM (pH 5.8) (C) cultures from strains with different genetic backgrounds: the wild type (wt) and iolR, iolR phoP, iolR ssrB,
and iolR rcsC55mutants. Means and standard deviations from duplicate experiments are represented. Expression of srfJ at the protein level was monitored using
an SrfJ-3FLAG fusion. An anti-FLAG antibody was used to detect the fusion protein by immunoblotting in extracts from cultures in LB–0.3 M NaCl (B) or
LPM (pH 5.8) (D) of S. enterica serovar Typhimurium strains with the indicated genetic backgrounds (upper panels). An anti-GroEL antibody was used as a
loading control (lower panels). Complementation of the effect of the iolR mutation on srfJ transcription observed in LB–0.3 M NaCl cultures expressing
wild-type iolR (iolR) from a PBAD promoter was demonstrated at the transcriptional level (E) and the protein level (F).
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nated with expression of SPI2. In fact, high expression is observed
in LPM (pH 5.8), a medium that mimics some of the conditions
found inside the SCV and activates some regulators that are acti-
vated within the phagosome. Our experiments reveal that both
acidic pH and Mg2 limitation are important factors in the regu-
lation of srfJ. Transcription of srfJ is positively regulated by the
two-component systems PhoP/PhoQ and SsrA/SsrB and nega-
tively regulated by the RcsC/RcsD/RcsB phosphorelay system.
Our epistasis experiments suggest that, whereas PhoP regulation
is SsrB dependent, RcsB acts independently from the other two
regulators. Positive regulation by PhoP is consistent with expres-
sion in LPM (pH 5.8), since the PhoQ sensor is activated in re-
sponse to low Mg2 concentrations and acidic pH (31, 47). Reg-
ulation of SPI2 genes by the two-component system PhoP/PhoQ
occurs because PhoP controls expression of ssrB and ssrA at tran-
scriptional and posttranscriptional levels, respectively (3). Here,
we show that the same regulatory cascade affects srfJ, a T3SS2-
related gene located outside SPI2. The Rcs system is also involved
in the control of Salmonella virulence (13, 14, 19, 42) through the
regulation of many genes, including SPI1 and SPI2 genes (35, 59).
A general regulatory overlap between Rcs and PhoP/PhoQ in the
control of Salmonella virulence was already shown (18). The reg-
ulation of srfJby both systems is a new element contributing to this
overlap.
Using a T-POP-based screen, we have identified IolR as an
unexpected regulator of srfJ. IolR is the main regulator of five
operons, encompassing the genes iolA-iolB, iolE-iolG1, iolC1-
iolC2, iolD1-iolD2-iolG2, and iolI2-iolH, which are involved in the
utilization ofmyo-inositol as a carbon source (33). Transcription
of these operons is repressed inminimalmediumwith glucose and
induced in minimal medium with myo-inositol. Deletion of iolR
resulted in stimulation of the transcription of the iol operons in
minimal medium with glucose, suggesting that the IolR protein
was a repressor. In fact, IolR is similar to proteins belonging to the
RpiR family of transcriptional regulators. The iol operons and the
iolR gene are located in a 22.6-kb genomic island. Sequence com-
parisons using BLAST identified this island in the genomes of S.
enterica serovar Typhimurium strains LT2, 14028, D23580, UK-1,
T000240, ST4/74, and SL1344; S. enterica serovar Paratyphi B
strain SPB7; S. enterica serovar Agona strain SL483; S. enterica
serovar Weltevreden strain 2007-60-3289-1; and E. coli ED1a.
Most genes in the island are absent from the genomes of Salmo-
nella bongori and certain S. enterica strains from serovars Typhi,
Paratyphi, Gallinarum, Enteritidis, Dublin, andDiarizonae. Inter-
estingly, srfJ is present, downstream of iolG1, in the strains that
contain the island and is absent from the genomes of the strains
that lack the island.
The IolR repressor is expected to be inactivated in the presence
ofmyo-inositol. Consistent with this notion, addition of this sugar
to LB–0.3MNaCl, amediumwhere srfJ exhibits a very low level of
expression, had the same effect as the iolR null mutation and re-
sulted in a more than 200-fold increase in srfJ transcription. The
iolR mutation, or the addition of myo-inositol, failed to induce
expression of srfJ in LPM.This result suggests that IolR can repress
srfJ when SsrB is inactive but not when SsrB is active (LB–0.3 M
NaCl versus LPM). In fact, the iolR mutation significantly in-
creased transcription of srfJ in LPM when tested in an ssrB back-
ground.
Our results show that srfJ can be expressed in two different
physiological conditions: (i) intracellularly inside the SCV (con-
ditionsmimicked by LPM) in coordination with T3SS2 and (ii) in
the presence ofmyo-inositol, a carbohydrate abundant in soil and
plants.Whereas intracellular expression is consistent with SrfJ be-
ing a T3SS2 effector, the significance of myo-inositol-dependent
expression is unclear. In fact, SrfJ is not secreted in LB–0.3 M
NaCl supplemented with myo-inositol in spite of its high level of
expression, probably owing to the lack of T3SS2 under these con-
ditions. One possibility is that accumulation of SrfJ before inges-
tion by the host animal (i.e., in environments wheremyo-inositol
is present) is advantageous for early secretion as soon as bacteria
enter the host cells and the T3SS2 is mounted. However, an inde-
pendent role for SrfJ in environments wheremyo-inositol is pres-
ent cannot be excluded. In support of this idea is the fact that srfJ
and themyo-inositol utilization island are present in E. coli ED1a
(10, 56), a human host-specific commensal strain belonging to
genetic group B2 that is avirulent in a mouse model of extraintes-
tinal infection and does not possess an identified virulence-related
T3SS.
Finally, the identification of a new T3SS effector opens the way
FIG 6 myo-inositol induces expression, but not secretion, of srfJ in LB–0.3 M
NaCl. (A) Expression of srfJ at the transcriptional level was monitored using a
chromosomal srfJ::lacZ fusion. Strains carrying the indicated mutations were
cultured in LB–0.3 M NaCl medium or LB–0.3 M NaCl medium supple-
mented withmyo-inositol. Expression of ssaV in LB–0.3MNaClmedium ()
or the same medium supplemented with myo-inositol () was monitored
using a chromosomal ssaV::lacZ transcriptional fusion. Means and standard
deviations from duplicate experiments are represented. (B) Expression and
secretion of srfJ at the protein level was monitored using an SrfJ-3FLAG
fusion. An anti-FLAG antibody was used to detect the fusion protein by im-
munoblotting in cell lysates and in concentrated supernatants from cultures in
LB–0.3 M NaCl medium of S. enterica serovar Typhimurium strains with the
indicated mutations (upper panel). An anti-GroEL antibody was used as the
loading control (lower panel). wt, wild type; MI,myo-inositol.
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to physiological studies. SrfJ is especially interesting because it
contains a C-terminal domain that is similar to human lysosomal
glucosylceramidase (also known as acid -glucocerebrosidase or
acid -glucosidase). Both proteins share 30% amino acid se-
quence identity over 447 residues and show structural similarities
in the overall fold and the active-site environment (32). The hu-
man enzyme catalyzes the hydrolysis of glucosylceramide to
-glucose and ceramide (23). Ceramide is a lipid molecule com-
posed of sphingosine and a fatty acid. The formation of ceramide
within the cell membrane alters biophysical characteristics of
membranes and leads to the generation of ceramide-enriched
membrane domains. These domains have a general function in
signal transduction through amplification of receptor- and stress-
mediated signaling events (66).Well-known events modulated by
ceramide include differentiation, proliferation, and apoptosis. In
addition, ceramide and ceramide-enriched membrane domains
have been involved in host responses to many pathogens (24).
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